You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for Patent: 10,857,102

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,857,102 protect, and when does it expire?

Patent 10,857,102 protects COMPLERA and is included in one NDA.

This patent has fifty-four patent family members in thirty-six countries.

Summary for Patent: 10,857,102

Title:	Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarate
Abstract:	The invention provides multilayer tablets that contain rilpivirine hydrochloride, emtricitabine, and tenofivir disoproxil fumarate. The tablets are useful for the treatment of HIV.
Inventor(s):	Oliyai; Reza (Burlingame, CA), Wiser; Lauren (Cupertino, CA), Menning; Mark (San Francisco, CA)
Assignee:	Gilead Sciences, Inc. (Foster City, CA) Janssen Sciences Ireland UC (Little Island, IE)
Application Number:	13/988,072
Patent Claim Types: see list of patent claims	Compound; Dosage form;

Drugs Protected by US Patent 10,857,102

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Gilead Sciences Inc	COMPLERA	emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate	TABLET;ORAL	202123-001	Aug 10, 2011		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 10,857,102

PCT Information
PCT Filed	November 18, 2011	PCT Application Number:	PCT/US2011/061515
PCT Publication Date:	May 24, 2012	PCT Publication Number:	WO2012/068535

International Family Members for US Patent 10,857,102

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
African Regional IP Organization (ARIPO)	3816	⤷ Sign Up
Argentina	084500	⤷ Sign Up
Argentina	123409	⤷ Sign Up
Australia	2011329642	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.